Drug Extravasation (DBCOND0029080)

Identifiers

Synonyms

Drug extravasations / Extravasation / Extravasation NOS / Extravasation (morphologic abnormality)

Associated Data

Indicated Drugs and Targets

Drug	Description	Targets
Dexrazoxane	A cytoprotective drug used to prevent and improve cardiomyopathy associated with doxorubicin treatment for metastatic breast cancer.	DNA topoisomerase 2-alphatarget DNA topoisomerase 2-betatarget
Hyaluronidase (human recombinant)	An enzyme used to improve the absorption and dispersion of parenterally administered fluids, drugs, and contrast agents.	Hyaluronic acidtarget Transforming growth factor beta-1 proproteintarget

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT06615063	Limb Splinting for Intravenous Cannulae in Neonates and Its Effects on Life Span of Intravenous Cannulae	No drug interventions	supportive_care	Not Available	completed
NCT00548704	A Clinical Trial on Topotect® (Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracyclines	Dexrazoxane	treatment	2 / 3	completed
NCT03889678	Color Doppler and Peripheral Venous Catheters	No drug interventions	Not Available	Not Available	completed
NCT01458873	Intravenous Sodium Bicarbonate Verifies Intravenous Position of Catheters in Spontaneously Breathing Adult Volunteers	Sodium bicarbonate	diagnostic	2 / 3	unknown_status
NCT01476293	Monitoring the Peripheral Intravenous Infusion Site for Infiltration and Extravasation	No drug interventions	Not Available	Not Available	completed
NCT00004890	Biomed 101 and Interleukin-2 in Treating Patients With Kidney Cancer	Aldesleukin Biomed 101	treatment	1	completed